BofA raised the firm’s price target on Herbalife (HLF) to $9 from $8 and keeps an Underperform rating on the shares. The firm adjusted its estimates after Q4 results came in “largely in line” and 2026 guidance was introduced.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLF: